Вы находитесь на странице: 1из 10

170 . 7 (141) . 2017 .

GO2 ,
Green O2 ( ) , , ,
, , ,
, , -
. ,
, - .
,
,
, , -
, , ,
, , -
.
. .

1. // . URL: http://www. vashsad. ua/plants/interesting_plants/


show/9275/ ( : 14.02.2017).
2. : // . URL: http://www.
izuminki. com/2012/10/11/malenkie-zelyonye-platya-ekologicheskaya-klassika-ot-nikol-dekstras/ ( -
: 14.02.2017).
3. : GO // BE IN OPEN. URL: https://www. be-in. ru/people/35485go-olya/ ( :
14.02.2017).
4. ,.., .. . -
// . 2013. 4.; URL: https://www. science-education.
ru/ru/article/view?id=9670 ( : 13.02.2017).
5. - // novate.
URL: http://www. novate. ru/blogs/191014/28185/ ( : 15.02.2017).


, ,
(. )

-
, , () [110].
: (1)
(DDREF) (2)
(). , , , -
[11].
[3,8,10].

1. DDREF
/2. DDREF
()
(DDREF), - [13].
, - DDREF ,
[9]. [1417]. -
. DDREF, - ,
- [17,18].
() ,
, 2 [12]. , , , -
, - [15].
Young Scientist . # 7 (141) . February 2017 Ecology 171

, -
- [31]; , -
-. , , --
( -) [14,32].
[19]. - -
DDREF [12]. - [14].
DDREF -
, [33]. -
. , (fitting)
- -
. - -
, ; -
, -
[20]. , - [34].
[35].
; , -
. - -
, DDREF [12,31,36,37]; ,
, - -
, - (. ). -
, [21]. ,
[13,10]. , -
, -
, . ., [22]. ()
- [5,7].
-
.. [23]. 0,52
, - , -
- [3840]. -
3100 , ( 10000 -,
) 3,5 ,
700 [24]. ,
-
,
. , - [41,42].
- 1 -
[25]. ;
-
(), . , -
()
[26,27]. , - [41,42], -
-
; , - .
[26,28]. - -
, , , , . ., -

( ), - [36,37,43].
(-
. - -, , -)
250 ; [31,4449].
. -, -
, -
, - - ,
[5051]. -
200 [15,29,30]. , ,

172 . 7 (141) . 2017 .

, - . -
, -
, [64,65],
(observational bias) [52]. , .
,
- -
. , [15,16],
, . ., (odds averaging) -
[53]. 90% -
0,1 [48]. , - [14].
, . , -
0,91 [44].
, . --
, -
[54]. ; ,
,
4050 .
40 [55]. BEIR VII,
- - (
) [15,16] -
[26]. , , -
[66] . . -
-
12 - - () [15]
[55]. , . , ,
(bias) -
, , 50100 -
[6,7]. , - 1050 [20], -
- - -
, [56,57].
1 -- 90 [67], -
-
, , . .
[44] ( -
), - [13,14,18,23,24]. , -
. - ,
. . DDREF [12]. -
-
0,1 [45]. , , , -
, ,
, , . [68].
- [69].
[4449]
, - ,
[36,37,43,5862]. -
. , -
a priori ,
, - ;
, ,
[1,2]. ,
, - , -
[1,63]. , ,
- recall bias [52]: ,
( ) - [70,71].
, , -,
, -
Young Scientist . # 7 (141) . February 2017 Ecology 173

. - ,
, RET/PTC3
, . [84] 1998 . , RET/PTC
1000 , DDREF -
110 4 [27]. . ,

DDREF 2 [19]. - RET/PTC1 [88]. -
[16]. , RET/PTC1
- RET [88], ,
, - RET/ PTC3, RET/PTC1. -
. , RET -
- [84,89,90], -, ,
- -
DDREF, - RET,
de novo [89]. -
. , RET/PTC -
,
2. . ; , .
, RET/PTC
,
RET ( , RET/PTC3) (clusters) , -
() - ,
- [89,91].
[72,73]. - RET/PTC3
, RET/PTC3 , . .,
[74]. - . -
, - RET -
, - , [90], -
, - ,
. , - . -
, , , RET/PTC IIIIV ,
. [87,92], -
, , RET, , RET/PTC3 -
in vitro, ,
, [93,94]. -
[7579]. ..- RET/PTC3, RET/PTC1 [94].
RET/PTC -
in vitro 0,1 [80] - RET/PTC3, -
[77,78]. . [95].
10 , 63 %
RET/PTC3 [96]
4000 RET
[81] . - [97,98]. , RET/PTC1 81%
[2,4,8] - , 10
, RET - [96]. RET ( RET/
, RET/ PTC3)
PTC3 . - , -
[82], - , T4 [96,99]. -
[8386] , RET/PTC , RET/PTC,
, (BRAF, RAS, PAX8PPAR)
. ,
(19952001 .); 1 4 [92]. -
[87]. [83 ; , -
86] RET/PTC .
, -
: RET/PTC1 - : , -
174 . 7 (141) . 2017 .

19811985 . 15 ;
, 3, ,
0,3 ; , - . RET/PTC -
, 25 0,5. : RET -
1,0 0,1 [100,101]. ; RET-
: RET/PTC1 , RET/PTC3
15 , 1971 1985 [74,96]. -
. - :
19 - -1 -
[102] ( [98], RET ( 10,3%) [110,111], ,
) , [4].
10 , RET -
24 [103]. RET/PTC1 [111].
2008 [112] -
, RET/PTC -
19861990 ., . .
: - RET/PTC
. -
10 24 - ,
[11], , - RET/PTC
. RET/PTC1. RET/PTC3
: The background [112].
rate of thyroid cancer among children under age 10 years , RET/
is approximately 2 to 4 cases per million per year [11]. PTC [113].
[100] --
. , - .
[11] -; . -
[100,101]. . RET/PTC
- [114,115],
1989 ,
[74]. - [116]. , -
- RET/PTC3
[104,105]. , - [117].
[106], ,
. - RET/PTC1 [90,117]. ,
[106] - -
[100,101] , , .
- RET/PTC3 [118],
[8]. . RET/PTC3 -
,
[107]. - : 64,7% 42,9% [119].
; [74], RET/PTC
- [82,110,120],
. - [120],
-
(19861996) .
[108]. T4 -
50% 224 -
. 4
: 71% [108]. , , -
- RET
[109]. , , , RET/
- PTC3 , RET/
, - PTC1. ,
. - ,
- , -
Young Scientist . # 7 (141) . February 2017 Ecology 175

[98]
- .
, , [124], -
, , -
. - ,
-
, , , -
. RET - .
, [94], ,
- -
/ [95,121]. -
, ( .
) - .
, ( -
RET/PTC3, RET/PTC1; -
BRAF) [97,122,123] , ,
[105,
[97,122]. - 125]. -
.
,

1. ,.. . . .
. 2008; (3):1722.
2. ,.. . . . .
2011; (5):749.
3. Jargin,S.V.Thyroid carcinoma in children and adolescents resulting from the Chernobyl accident: possible causes of
the incidence increase overestimation. Cesk Patol 2009;45:502.
4. Jargin,S.V.On the RET rearrangements in Chernobyl-related thyroid cancer. J.Thyroid Res 2012;2012:373879.
5. Jargin,S.V.On the low-dose-radiation exposure in the Techa River Cohort and mortality from circulatory diseases.
Radiat Environ Biophys 2013;52:41920.
6. Jargin,S.V.On the radiation-leukemia dose-response relationship among recovery workers after the Chernobyl
accident. Dose Response 2013;12:1625.
7. Jargin,S.V.Leukemia and cardiovascular diseases in the Techa river cohort. J Environ Occup Sci 2014;3:634.
8. Jargin,S.V.Chernobyl-related cancer and precancerous lesions: Incidence increase vs. late diagnostics. Dose
Response 2014;12:40414.
9. Jargin,S.V.Biological effectiveness of ionizing radiation: Acute vs. protracted exposures. J Environ Stud 2016;2:5.
10. Jargin,S.V.Hypothesis: overestimation of Chernobyl consequences. J.Environ. Occup Sci 2016;5:5965.
11. (UNSCEAR) 2008. D. -
.
12. Rhm,W., WoloschakG.E., ShoreR.E. et al. Dose and dose-rate effects of ionizing radiation: a discussion in the
light of radiological protection. Radiat Environ Biophys 2015;54:379401.
13. ICRP. Low-dose extrapolation of radiation-related cancer risk. ICRP Publication 99. Ann ICRP 2005;35 (4).
14. Doss,M.Linear no-threshold model vs. radiation hormesis. Dose Response 2013;11:48097.
15. ,.. : pro contra.
. . . . 2011; (1):1079.
16. ,.. --
. . . . 2008; (4):389408.
17. Tubiana,M., FeinendegenL.E., YangC., KaminskiJ.M.The linear no-threshold relationship is inconsistent with
radiation biologic and experimental data. Radiology 2009;251:1322.
18. Feinendegen,L.E.Evidence for beneficial low level radiation effects and radiation hormesis. Br J Radiol 2005;78:37.
19. Haley,B.M., PauneskuT., GrdinaD.J. et al. The increase in animal mortality risk following exposure to sparsely
ionizing radiation is not linear quadratic with dose. PLoS One 2015;10: e0140989.
20. Brenner,D.J., DollR., GoodheadD.T. et al. Cancer risks attributable to low doses of ionizing radiation: assessing
what we really know. Proc Natl Acad Sci USA 2003;100:137616.
176 . 7 (141) . 2017 .

21. Karam,P.A., LeslieS.A.Calculations of background beta-gamma radiation dose through geologic time. Health Phys
1999;77:6627.
22. Kaludercic,N., DeshwalS., Di LisaF.Reactive oxygen species and redox compartmentalization. Front Physiol
2014;5:285.
23. ,.. . : , 1995.
24. Mitchel,R.E.The dose window for radiation-induced protective adaptive responses. Dose Response 2009;8:192
208.
25. Shuryak,I., BrennerD.J., UllrichR.L.Radiation-induced carcinogenesis: mechanistically based differences between
gamma-rays and neutrons, and interactions with DMBA. PLoS One 2011;6: e28559.
26. National Research Council of the National Academies. Health risks from exposure to low levels of ionizing radiation
(BEIR VII Phase 2). Washington, D.C.: National Acad Press, 2006.
27. UNSCEAR 1993 Report. Annex F: Influence of Dose and Dose Rate on Stochastic Effects of Radiation.
28. Task Group on Radiation Quality Effects in Radiological Protection. Relative biological effectiveness (RBE), quality
factor (Q), and radiation weighting factor (w (R)). Ann ICRP 2003;33 (4):1117.
29. Little,M.P., MuirheadC.R.Curvature in the cancer mortality dose response in Japanese atomic bomb survivors:
absence of evidence of threshold. Int J Radiat Biol 1998;74:47180.
30. Heidenreich,W.F., ParetzkeH.G., JacobP.No evidence for increased tumor rates below 200 mSv in the atomic bomb
survivors data. Radiat Environ Biophys 1997;36:2057.
31. Ozasa,K., ShimizuY., SuyamaA. et al. Studies of the mortality of atomic bomb survivors, Report 14, 19502003:
an overview of cancer and noncancer diseases. Radiat Res 2012;177:22943.
32. Cuttler,J.M.Remedy for radiation fear discard the politicized science. Dose Response 2014;12:17084.
33. Sasaki,M.S., TachibanaA., TakedaS.Cancer risk at low doses of ionizing radiation: artificial neural networks
inference from atomic bomb survivors. J Radiat Res 2014;55:391406.
34. Dourson,M., BeckerR.A., HaberL.T. et al. Advancing human health risk assessment: integrating recent advisory
committee recommendations. Crit Rev Toxicol 2013;43:46792.
35. Jargin,S.V.On the mathematical modeling of radiation-related abnormalities in humans. Molodoi Uchenyi Young
Scientist 2014; (19):468.
36. Krestinina,L.Y., DavisF.G., SchonfeldS. et al. Leukaemia incidence in the Techa River Cohort: 19532007. Br J
Cancer 2013;109:288693.
37. Ostroumova,E., PrestonD.L., RonE. et al. Breast cancer incidence following low-dose rate environmental exposure:
Techa River Cohort, 19562004. Br J Cancer 2008;99:19405.
38. ,.., .., .. .
. . . 1990; (12):115.
39. ,.., .., .. . -
. . . . 2000; (6):104.
40. Tokarskaya,Z.B., ScottB.R., ZhuntovaG.V. et al. Interaction of radiation and smoking in lung cancer induction
among workers at the Mayak nuclear enterprise. Health Phys 2002;83:83346.
41. ,.., ., ..- -
. . . . 2004; (3):306.
42. ,.., .., .. . , -
. : , 2001.
43. ,.., .. .
2010; (6):349.
44. ,.., .., .. -
, 19481958 . . . .
2012; (2):14957.
45. ,.., ., .. . -
: 19481982. . . . 2015; (4):4361.
46. Azizova,T.V., MuirheadC.R., DruzhininaM.B. et al. Cardiovascular diseases in the cohort of workers first employed
at Mayak PA in 19481958. Radiat Res 2010;174:15568.
47. Azizova,T.V., ZhuntovaG.V., HaylockR.G. et al. Chronic bronchitis in the cohort of Mayak workers first employed
19481958. Radiat Res 2013;180:61021.
48. Krestinina,L.Y., EpifanovaS., SilkinS. et al. Chronic low-dose exposure in the Techa River Cohort: risk of mortality
from circulatory diseases. Radiat Environ Biophys 2013;52:4757.
49. Yablokov,A.V.Nonmalignant diseases after the Chernobyl catastrophe. Ann N Y Acad Sci 2009;1181:58160.
Young Scientist . # 7 (141) . February 2017 Ecology 177

50. Zablotska,L.B., BazykaD., LubinJ.H. et al. Radiation and the risk of chronic lymphocytic and other leukemias
among Chornobyl cleanup workers. Environ Health Perspect 2013;121:5965.
51. McGeoghegan, D., BinksK., GilliesM. et al. The non-cancer mortality experience of male workers at British Nuclear
Fuels plc, 19462005. Int J Epidemiol 2008;37:50618.
52. Watanabe,T., MiyaoM., HondaR. et al. Hiroshima survivors exposed to very low doses of A-bomb primary radiation
showed a high risk for cancers. Environ. Health Prev Med 2008;13:26470.
53. Smith,J., BeresfordN.A.Chernobyl Catastrophe and Consequences. Chichester: Springer, 2005. P. 23966.
54. Vallis,K.A., PintilieM., ChongN. et al. Assessment of coronary heart disease morbidity and mortality after radiation
therapy for early breast cancer. J Clin Oncol 2002;20:103642.
55. UNSCEAR 2006 Report. Annex B: Epidemiological evaluation of cardiovascular disease and other non-cancer
diseases following radiation exposure.
56. UNSCEAR 1962 Report. Annex D: Somatic effects of radiation.
57. Schultz-Hector,S.Radiation-induced heart disease: review of experimental data on dose response and pathogenesis.
Int J Radiat Biol 1992;61:14960.
58. Krestinina,L.Y., DavisF., OstroumovaE. et al. Solid cancer incidence and low-dose-rate radiation exposures in the
Techa River cohort: 19562002. Int J Epidemiol 2007;36:103846.
59. Sokolnikov,M., PrestonD., GilbertE. et al. Radiation effects on mortality from solid cancers other than lung, liver,
and bone cancer in the Mayak worker cohort: 19482008. PLoS One 2015;10: e0117784.
60. Azizova,T.V., KorobkinA.V., OsovetsS.V., BannikovaM.V.Latency period of acute leukemia in the cohort of Mayak
workers. Chronic radiation exposure: low-dose effects. In: Abstracts of the 4th International Conference, Nov. 911,
2010, Chelyabinsk; 2010. P. 145.
61. Yablokov,A.V.Oncological diseases after the Chernobyl catastrophe. Ann N Y AcadSci. 2009;1181:16191.
62. Ivanov,V.K., GorskiA.I., TsybA.F. et al. Solid cancer incidence among the Chernobyl emergency workers residing
in Russia: estimation of radiation risks. Radiat Environ Biophys 2004;43:3542.
63. Jargin,S.V.Unfounded statements tending to overestimate Chernobyl consequences. J Radiol Prot 2013;33:8814.
64. Duport,P., JiangH., ShilnikovaN.S. et al. Database of radiogenic cancer in experimental animals exposed to low
doses of ionizing radiation. J Toxicol Environ Health. B Crit. Rev 2012;15:186209.
65. Dreicer,M.Book review. Chernobyl: Consequences of the catastrophe for people and the environment. Environ
Health Perspect 2010;118: A500.
66. Bertell,R.Behind the cover-up. Assessing conservatively the full Chernobyl death toll. Pacific Ecologist 2006; Winter.
67. Ron,E., ModanB., PrestonD. et al. Thyroid neoplasia following low-dose radiation in childhood. Radiat Res
1989;120:51631.
68. Tanaka,S., TanakaI.B. 3rd, SasagawaS. et al. No lengthening of life span in mice continuously exposed to gamma
rays at very low dose rates. Radiat Res 2003;160:3769.
69. Caratero,A., CourtadeM., BonnetL. et al. Effect of a continuous gamma irradiation at a very low dose on the life
span of mice. Gerontology 1998;44:2726.
70. Little,J.B.Low-dose radiation effects: interactions and synergism. Health Phys 1990;59:4955.
71. Jargin,S.V.Hormetic use of stress in gerontological interventions requires a cautious approach. Biogerontology
2016;17:41722.
72. Nikiforov,Y. E.Radiation-induced thyroid cancer: what we have learned from Chernobyl. Endocr Pathol
2006;17:30717.
73. Nikiforov,Y.E., NikiforovaM.N.Molecular genetics and diagnosis of thyroid cancer. Nat Rev Endocrinol
2011;7:56980.
74. ,.., .., . . : -
, 2006.
75. Matsuu-Matsuyama,M., ShichijoK., OkaichiK. et al. Effect of age on the sensitivity of the rat thyroid gland to
ionizing radiation. J Radiat Res 2015;56:493501.
76. Lee,W., ChiacchieriniR.P., ShleienB., TellesN.C.Thyroid tumors following 131I or localized X irradiation to the
thyroid and pituitary glands in rats. Radiat Res 1982;92:30719.
77. Mizuno,T., IwamotoK.S., KyoizumiS. et al. Preferential induction of RET/PTC1 rearrangement by X-ray irradiation.
Oncogene 2000;19:43843.
78. Ito,T., SeyamaT., IwamotoK.S. et al. In vitro irradiation is able to cause RET oncogene rearrangement. Cancer Res
1993;53:29403.
79. Finn,S.P., SmythP., OReganE. et al. Array comparative genomic hybridisation analysis of gamma-irradiated
human thyrocytes. Virchows Arch 2004;445:396404.
178 . 7 (141) . 2017 .

80. Caudill,C.M., ZhuZ., CiampiR., StringerJ.R., NikiforovY.E.Dose-dependent generation of RET/PTC in human


thyroid cells after in vitro exposure to gamma-radiation: a model of carcinogenic chromosomal rearrangement induced
by ionizing radiation. J Clin Endocrinol Metab 2005;90:23649.
81. Nikiforov,Y. E.Is ionizing radiation responsible for the increasing incidence of thyroid cancer? Cancer
2010;116:16268.
82. ,.., .., .., .. RET/PTC -
-
(pooled-). . . . 2016; (1):519.
83. Viglietto,G., ChiappettaG., Marchinez-TelloF.J. et al. RET-PTC oncogene activation is an early event in thyroid
carcinogenesis. Oncogene 1995;11:120710.
84. Tallini,G., SantoroM., HelieM. et al. RET/PTC oncogene activation defines a subset of papillary thyroid carcinomas
lacking evidence of progression to poorly differentiated or undifferentiated tumor phenotypes. Clin Cancer Res
1998;4:28794.
85. Sugg,S.L., EzzatSh., RosenI.B. et al. Distinct multiple RET/PTC gene rearrangements in multifocal papillary
thyroid neoplasia. J Clin Endocrinol Metab 1998;83:411622.
86. Corvi,R., Martinez-AlfaroM., HarachH.R. et al. Frequent RET rearrangements in thyroid papillary microcarcinoma
detected by interphase fluorescence in situ hybridization. Lab Invest 2001;81:163945.
87. Menicali,E., MorettiS., VoceP. et al. Intracellular signal transduction and modification of the tumor microenvironment
induced by RET/PTCs in papillary thyroid carcinoma. Front Endocrinol (Lausanne) 2012;3:67.
88. Rhoden,K.J., JohnsonC., BrandaoG. et al. Real-time quantitative RT-PCR identifies distinct c-RET, RET/PTC1
and RET/PTC3 expression patterns in papillary thyroid carcinoma. Lab Invest 2004;84:155770.
89. Pfeifer,J.D.Molecular genetic testing in surgical pathology. Lippincott: Philadelphia, 2006.
90. Dabbs,D.J.Diagnostic immunohistochemistry: Theranostic and genomic applications. 3rd edition. Saunders-
Elsevier, Philadelphia, 2010. P. 291339.
91. Unger,K., ZitzelsbergerH., SalvatoreG. et al. Heterogeneity in the distribution of RET/PTC rearrangements within
individual post-Chernobyl papillary thyroid carcinomas. J Clin Endocrinol Metab 2004;89:42729.
92. Yip,L., NikiforovaM.N., YooJ.Y. et al. Tumor genotype determines phenotype and disease-related outcomes in
thyroid cancer: a study of 1510 patients. Ann Surg 2015;262:51925.
93. Romei,C., EliseiR.RET/PTC Translocations and clinico-pathological features in human papillary thyroid carcinoma.
Front Endocrinol (Lausanne) 2012;3:54.
94. Prescott,J.D., ZeigerM.A.The RET oncogene in papillary thyroid carcinoma. Cancer 2015;121:213746.
95. Cordioli,M.I., MoraesL., BastosA.U. et al. Fusion oncogenes are the main genetic events found in sporadic papillary
thyroid carcinomas from children. Thyroid 2017;27:1828.
96. Rabes,H.M., DemidchikE.P., SidorowJ.D. et al. Pattern of radiation-induced RET and NTRK1 rearrangements in
191 post-Chernobyl papillary thyroid carcinomas: biological, phenotypic, and clinical implications. Clin Cancer Res
2000;6:1093103.
97. Trovisco,V., SoaresP., PretoA. et al. Molecular genetics of papillary thyroid carcinoma: great expectations. Arq Bras
Endocrinol Metabol 2007;51:64353.
98. Williams,D.Radiation carcinogenesis: lessons from Chernobyl. Oncogene 2008;27 Suppl 2: S9S18.
99. Bongarzone,I., VigneriP., MarianiL. et al. RET/NTRK1 rearrangements in thyroid gland tumors of the papillary
carcinoma family: correlation with clinicopathological features. Clin Cancer Res 1998;4:2238.
100. Stsjazhko,V.A., TsybA.F., TronkoN.D. et al. Childhood thyroid cancer since accident at Chernobyl. BMJ
1995;310:801.
101. IARC. Ionizing radiation, part 2: some internally deposited radionuclides. IARC Monogr Eval Carcinog Risks Hum
2001;78 (Pt 2):2336.
102. ,.., .., .., ..- -
. . . 2014; (2):436.
103. ,..
(2008): . . . . 2011; (6):1523.
104. UNSCEAR 1994 Report. AnnexA.Epidemiological studies of radiation carcinogenesis.
105. Jaworowski,Z.Observations on the Chernobyl disaster and LNT. Dose Response 2010;8:14871.
106. Demidchik,Y.E., SaenkoV.A., YamashitaS.Childhood thyroid cancer in Belarus, Russia, and Ukraine after
Chernobyl and at present. Arq Bras Endocrinol Metabol 2007;51:74862.
107. ,.., .., .., .. -
. . . 1995; (5):5405.
Young Scientist . # 7 (141) . February 2017 Ecology 179

108. Tronko,M.D., BogdanovaT.I., KomissarenkoI.V. et al. Thyroid carcinoma in children and adolescents in Ukraine
after the Chernobyl nuclear accident: statistical data and clinicomorphologic characteristics. Cancer 1999;86:149
56.
109. Williams,E.D., AbrosimovA., BogdanovaT. et al. Thyroid carcinoma after Chernobyl latent period, morphology and
aggressiveness. Br J Cancer 2004;90:221924.
110. Vuong,H.G., AltibiA.M., AbdelhamidA.H. et al. The changing characteristics and molecular profiles of papillary
thyroid carcinoma over time: a systematic review. Oncotarget 2016; doi: 10.18632/oncotarget. 12885
111. Mitsutake,N., FukushimaT., MatsuseM. et al. BRAF (V600E) mutation is highly prevalent in thyroid carcinomas in
the young population in Fukushima: a different oncogenic profile from Chernobyl. Sci Rep 2015;5:16976.
112. ,.., .., .. - RET/
PTC . --
. . . . 2016; (1):525.
113. Tuttle,R.M., LukesY., OnstadL. et al. ret/PTC activation is not associated with individual radiation dose estimates
in a pilot study of neoplastic thyroid nodules arising in Russian children and adults exposed to Chernobyl fallout.
Thyroid 2008;18:83946.
114. Leeman-Neill,R.J., BrennerA.V., LittleM.P. et al. RET/PTC and PAX8/PPAR chromosomal rearrangements in
post-Chernobyl thyroid cancer and their association with iodine-131 radiation dose and other characteristics. Cancer
2013;119:17929.
115. Hamatani,K., EguchiH., ItoR. et al. RET/PTC rearrangements preferentially occurred in papillary thyroid cancer
among atomic bomb survivors exposed to high radiation dose. Cancer Res 2008;68:717682.
116. Nakachi,K., HayashiT., HamataniK. et al. Sixty years of follow-up of Hiroshima and Nagasaki survivors: current
progress in molecular epidemiology studies. Mutat Res 2008;659:10917.
117. Nikiforov,Y.E.Molecular diagnostics of thyroid tumors. Arch Pathol Lab Med 2011;135:56977.
118. Rao,P.J., VardhiniN.V., ParvathiM.V. et al. Prevalence of RET/PTC1 and RET/PTC3 gene rearrangements in
Chennai population and its correlation with clinical parameters. Tumour Biol 2014;35:953948.
119. Di CristofaroJ., VaskoV., SavchenkoV. et al. ret/PTC1 and ret/PTC3 in thyroid tumors from Chernobyl liquidators:
comparison with sporadic tumors from Ukrainian and French patients. Endocr Relat Cancer 2005;12:17383.
120. Jung,C.K., LittleM.P., LubinJ.H. et al. The increase in thyroid cancer incidence during the last four decades is
accompanied by a high frequency of BRAF mutations and a sharp increase in RAS mutations. J Clin Endocrinol
Metab 2014;99: E27685.
121. Leboulleux,S., BaudinE., HartlD.W. et al. Follicular cell-derived thyroid cancer in children. Horm Res 2005;63:145
51.
122. Suzuki,K., MitsutakeN., SaenkoV., YamashitaS.Radiation signatures in childhood thyroid cancers after the
Chernobyl accident: possible roles of radiation in carcinogenesis. Cancer Sci 2015;106:12733.
123. Jarzab,B., Handkiewicz-JunakD.Differentiated thyroid cancer in children and adults: same or distinct disease?
Hormones (Athens) 2007;6:2009.
124. Akulevich,N.M., SaenkoV.A., RogounovitchT.I. et al. Polymorphisms of DNA damage response genes in radiation-
related and sporadic papillary thyroid carcinoma. Endocr Relat Cancer 2009;16:491503.
125. Kharecha PA, Hansen JE. Prevented mortality and greenhouse gas emissions from historical and projected nuclear
power. Environ Sci Technol 2013;47:488995.

Вам также может понравиться

  • tmpF475 TMP
    tmpF475 TMP
    Документ7 страниц
    tmpF475 TMP
    Frontiers
    Оценок пока нет
  • tmp6671 TMP
    tmp6671 TMP
    Документ22 страницы
    tmp6671 TMP
    Frontiers
    Оценок пока нет
  • tmpD191 TMP
    tmpD191 TMP
    Документ21 страница
    tmpD191 TMP
    Frontiers
    Оценок пока нет
  • Tmp59e8 TMP
    Tmp59e8 TMP
    Документ17 страниц
    Tmp59e8 TMP
    Frontiers
    Оценок пока нет
  • tmp8AB6 TMP
    tmp8AB6 TMP
    Документ319 страниц
    tmp8AB6 TMP
    Frontiers
    Оценок пока нет
  • tmp5118 TMP
    tmp5118 TMP
    Документ4 страницы
    tmp5118 TMP
    Frontiers
    Оценок пока нет
  • tmp4D6D TMP
    tmp4D6D TMP
    Документ3 страницы
    tmp4D6D TMP
    Frontiers
    Оценок пока нет
  • tmpB7B3 TMP
    tmpB7B3 TMP
    Документ6 страниц
    tmpB7B3 TMP
    Frontiers
    Оценок пока нет
  • tmpBA50 TMP
    tmpBA50 TMP
    Документ3 страницы
    tmpBA50 TMP
    Frontiers
    Оценок пока нет
  • Tmp46a8 TMP
    Tmp46a8 TMP
    Документ2 страницы
    Tmp46a8 TMP
    Frontiers
    Оценок пока нет
  • tmp90D3 TMP
    tmp90D3 TMP
    Документ3 страницы
    tmp90D3 TMP
    Frontiers
    Оценок пока нет
  • tmpF953 TMP
    tmpF953 TMP
    Документ6 страниц
    tmpF953 TMP
    Frontiers
    100% (1)
  • tmpC05C TMP
    tmpC05C TMP
    Документ4 страницы
    tmpC05C TMP
    Frontiers
    Оценок пока нет
  • tmpE6CC TMP
    tmpE6CC TMP
    Документ10 страниц
    tmpE6CC TMP
    Frontiers
    Оценок пока нет
  • tmpDB93 TMP
    tmpDB93 TMP
    Документ11 страниц
    tmpDB93 TMP
    Frontiers
    Оценок пока нет
  • tmpB09D TMP
    tmpB09D TMP
    Документ16 страниц
    tmpB09D TMP
    Frontiers
    Оценок пока нет
  • tmpFE19 TMP
    tmpFE19 TMP
    Документ6 страниц
    tmpFE19 TMP
    Frontiers
    Оценок пока нет
  • Tmp23a TMP
    Tmp23a TMP
    Документ11 страниц
    Tmp23a TMP
    Frontiers
    Оценок пока нет
  • tmp1B4E TMP
    tmp1B4E TMP
    Документ3 страницы
    tmp1B4E TMP
    Frontiers
    Оценок пока нет
  • tmp219B TMP
    tmp219B TMP
    Документ15 страниц
    tmp219B TMP
    Frontiers
    Оценок пока нет